VIDAL
Medicines
Parallel Import Medicine
This medicine has been the subject of a parallel import authorisation.
The information for this specialty (except for the Reimbursement section) is that of the specialty DEPAKINE CHRONO 500 mg, prolonged-release scored film-coated tablet which obtained a marketing authorisation (AMM) in France.
Please note that the excipients may be different from those of the specialty that obtained the marketing authorisation (AMM) in France.
Refer to the monograph of the specialty DEPAKINE CHRONO 500 mg, prolonged-release scored film-coated tablet.
SANT JOSEP 116 NAVE 2 SANT FELIU DE LLOBREGAT, B
08980 BARCELONA
Tel: 44 (0)3306 841 100 Tel (green number): 09 72 10 61 79
regulatory.france@difarmed.com
http://www.difarmed.com/
Medicines
Parallel Import Medicine
DEPAKINE CHRONO 500 mg, scored film-coated prolonged-release tablet [RO2]
This medicine has been the subject of a parallel import authorisation.
The information for this specialty (except for the Reimbursement section) is that of the specialty DEPAKINE CHRONO 500 mg, prolonged-release scored film-coated tablet which obtained a marketing authorisation (AMM) in France.
Please note that the excipients may be different from those of the specialty that obtained the marketing authorisation (AMM) in France.
Refer to the monograph of the specialty DEPAKINE CHRONO 500 mg, prolonged-release scored film-coated tablet.
Prescription, supply and reimbursement
List II
Medicinal product subject to initial prescription restricted to neurology and paediatric specialists: Female children and adolescents, women of childbearing potential and pregnant women: Initial annual prescription restricted to neurology or paediatric specialists. Renewal not restricted. Male adolescents and men of childbearing potential: Initial prescription restricted to neurology or paediatric specialists. Renewal not restricted.
Medicinal product subject to initial prescription restricted to neurology departments and paediatric departments: Female children and adolescents, women of childbearing potential and pregnant women: Initial annual prescription restricted to neurology or paediatric specialists. Renewal not restricted. Male adolescents and men of childbearing potential: Initial prescription restricted to neurology or paediatric specialists. Renewal not restricted.
Medicine requiring particular monitoring during treatment: the prescription requires the annual signature by the physician and the female patient or male patient of the shared information certificate. Dispensing requires presentation of the annual co-signed certificate.
Unrestricted renewal
Medicinal product subject to initial prescription restricted to neurology and paediatric specialists: Female children and adolescents, women of childbearing potential and pregnant women: Initial annual prescription restricted to neurology or paediatric specialists. Renewal not restricted. Male adolescents and men of childbearing potential: Initial prescription restricted to neurology or paediatric specialists. Renewal not restricted.
Medicinal product subject to initial prescription restricted to neurology departments and paediatric departments: Female children and adolescents, women of childbearing potential and pregnant women: Initial annual prescription restricted to neurology or paediatric specialists. Renewal not restricted. Male adolescents and men of childbearing potential: Initial prescription restricted to neurology or paediatric specialists. Renewal not restricted.
Medicine requiring particular monitoring during treatment: the prescription requires the annual signature by the physician and the female patient or male patient of the shared information certificate. Dispensing requires presentation of the annual co-signed certificate.
Unrestricted renewal
| Marketing authorisation (AMM) |
|
| Price: |
|
Social Security reimbursement at 65% based on the TFR: 6.81 euros (T/30) in the indications:
Collection.
Difarmed SL
- Indication(s) appearing in the marketing authorisation at the date of publication of this decree
Collection.
SANT JOSEP 116 NAVE 2 SANT FELIU DE LLOBREGAT, B
08980 BARCELONA
Tel: 44 (0)3306 841 100 Tel (green number): 09 72 10 61 79
regulatory.france@difarmed.com
http://www.difarmed.com/
Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.
